Picture of Vicapsys Life Sciences logo

VICP Vicapsys Life Sciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapTurnaround

Annual cashflow statement for Vicapsys Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-1.03-0.766-0.237-0.985
Amortisation
Non-Cash Items-0.0140.015-0.0960.446
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.0470.457-0.1430.269
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-0.97-0.263-0.444-0.238
Other Investing Cash Flow Items0.10
Sale/Maturity of Investment
Cash from Investing Activities0.10
Financing Cash Flow Items0.1770-0.015
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities1.1500.560.035
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.178-0.2630.216-0.203